Eupraxia Pharmaceuticals Pink Sheet Forecast - Naive Prediction
| EPRXF Stock | USD 2.67 0.05 1.91% |
The Naive Prediction forecasted value of Eupraxia Pharmaceuticals on the next trading day is expected to be 2.09 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 13.82. Eupraxia Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Eupraxia Pharmaceuticals stock prices and determine the direction of Eupraxia Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Eupraxia Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of Eupraxia Pharmaceuticals to cross-verify your projections. Eupraxia |
Most investors in Eupraxia Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Eupraxia Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Eupraxia Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
A naive forecasting model for Eupraxia Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Eupraxia Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period. Eupraxia Pharmaceuticals Naive Prediction Price Forecast For the 19th of April
Given 90 days horizon, the Naive Prediction forecasted value of Eupraxia Pharmaceuticals on the next trading day is expected to be 2.09 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.09, and the sum of the absolute errors of 13.82.Please note that although there have been many attempts to predict Eupraxia Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eupraxia Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eupraxia Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Eupraxia Pharmaceuticals | Eupraxia Pharmaceuticals Price Prediction | Buy or Sell Advice |
Eupraxia Pharmaceuticals Forecasted Value
In the context of forecasting Eupraxia Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Eupraxia Pharmaceuticals' downside and upside margins for the forecasting period are 0.03 and 8.46, respectively. We have considered Eupraxia Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Eupraxia Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Eupraxia Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.7423 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2266 |
| MAPE | Mean absolute percentage error | 0.06 |
| SAE | Sum of the absolute errors | 13.823 |
Predictive Modules for Eupraxia Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eupraxia Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eupraxia Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Eupraxia Pharmaceuticals
For every potential investor in Eupraxia, whether a beginner or expert, Eupraxia Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eupraxia Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eupraxia. Basic forecasting techniques help filter out the noise by identifying Eupraxia Pharmaceuticals' price trends.Eupraxia Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eupraxia Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Eupraxia Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eupraxia Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eupraxia Pharmaceuticals Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Eupraxia Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Eupraxia Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eupraxia Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Eupraxia Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eupraxia Pharmaceuticals pink sheet market strength indicators, traders can identify Eupraxia Pharmaceuticals entry and exit signals to maximize returns.
Eupraxia Pharmaceuticals Risk Indicators
The analysis of Eupraxia Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eupraxia Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eupraxia pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.79 | |||
| Standard Deviation | 6.33 | |||
| Variance | 40.07 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eupraxia Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eupraxia Pharmaceuticals' short interest history, or implied volatility extrapolated from Eupraxia Pharmaceuticals options trading.
Pair Trading with Eupraxia Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eupraxia Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Eupraxia Pink Sheet
| 0.81 | MRNA | Moderna Financial Report 2nd of May 2024 | PairCorr |
| 0.55 | NSFDF | NXT Energy Solutions | PairCorr |
The ability to find closely correlated positions to Eupraxia Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eupraxia Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eupraxia Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eupraxia Pharmaceuticals to buy it.
The correlation of Eupraxia Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eupraxia Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eupraxia Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eupraxia Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Eupraxia Pharmaceuticals to cross-verify your projections. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Eupraxia Pink Sheet analysis
When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |